Observational studyThe oncologist2024

Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy.

David O'Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.